Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Angelalign Technology Inc. ( (HK:6699) ).
Angelalign Technology has granted 123,753 restricted share units to 51 group employees under its post-IPO RSU scheme, with no purchase price and no performance targets attached. The awards, structured with multi-year vesting schedules and a clawback mechanism tied to employment status and transfer restrictions, are designed to enhance long-term motivation and align staff incentives with the company’s growth and remuneration practices.
The board and its remuneration committee argue that shorter vesting for part of the grant remains compliant with Hong Kong listing rules and in line with industry norms. The move underscores Angelalign’s continued reliance on equity-based compensation to remain competitive in talent retention, though the absence of performance conditions may draw scrutiny from investors focused on pay-for-performance alignment.
The most recent analyst rating on (HK:6699) stock is a Hold with a HK$73.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
More about Angelalign Technology Inc.
Angelalign Technology Inc. is a dental technology company specializing in invisible orthodontic solutions and related services. Listed in Hong Kong, the group focuses on leveraging post-IPO equity incentive schemes to attract and retain key talent in a competitive medical and dental technology market.
Average Trading Volume: 599,310
Technical Sentiment Signal: Hold
Current Market Cap: HK$11.36B
See more data about 6699 stock on TipRanks’ Stock Analysis page.

